Featured

TissueCypher enables risk-aligned management of patients with non-dysplastic Barrett’s esophagus: a case series at an expert foregut surgery center

Dr. John Lipham

Wisniowski P, Putnam L, Hall M, Smolko C, Critchley-Thorne RJ, Lipham JC

Gastrointestinal Endoscopy

View

An automated tissue systems pathology test can standardize the management and improve health outcomes for patients with Barrett’s esophagus

Dr. Lucas Duits

Duits LC, Khoshiwal, AM, Frei NF, Pouw, RE, Barrett’s SURF LGD Study Pathologists Consortium; Smolko C, Arora M, Siegel JJ, Critchley-Thorne RJ, Bergman JJ

American Journal of Gastroenterology

View

Bibliography

View Printable Bibliography

How TissueCypher Is Referenced in Publications

In most peer reviewed publications, a non-proprietary and non-branded product name is required for article acceptance. Below is a listing of names that have been used to generically describe TissueCypher, without referring to it by its brand name:

  • TSP-9 (Tissue Systems Pathology Test with 9 protein-based biomarkers)
  • Tissue Systems Pathology Test
  • Risk Prediction Test
  • Risk Prediction Assay
  • Risk Prediction Multi-Biomarker Assay